Strategic Objectives
• Master the chemical synthesis of high-stability lipid nanoparticles.
• Unlock the potential of gold clusters for precision imaging and delivery.
• Engineer polymer-based vehicles that bypass complex immune detection.
• Achieve safe, transient gene expression for scalable clinical applications.
The Core Challenge
Traditional viral vectors carry inherent risks of genomic integration, immune rejection, and manufacturing bottlenecks that stall therapeutic progress.
01
The Dawn of Non-Viral Delivery
02
Principles of Nanomedicine
03
Lipid Nanoparticles (LNPs)
04
The Chemistry of Cationic Lipids
05
Polymer-Based Vehicles
06
Gold Nanoclusters
07
Synthesis and Formulation Techniques
08
Overcoming the Blood-Brain Barrier
09
Evading the Immune System
10
The Role of PEGylation
11
Endocytosis and Cellular Entry
12
Endosomal Escape
13
Transient vs. Stable Expression
14
Toxicity and Biocompatibility
15
Characterization Techniques
16
Targeted Delivery Systems
17
RNA Interference (RNAi) Applications
18
Vaccine Development
19
Regulatory Pathways
20
Scale-Up and Manufacturing
21